EAS Newsletter October 31, 2023

EAS Governance:

If you haven’t submitted your abstract for the EAS Congress 2024 yet, don’t delay any further

Don’t hesitate. Many individuals are showing great interest in seizing this chance to engage in the exchange of novel research and ideas with scientists from across the world. This is a unique opportunity to take part in the prestigious 92nd EAS Congress.

Furthermore, please take the time to investigate the possibilities related to Young Investigator Fellowships and Travel Grants. You can find further information below.

The submission deadline is December 5, 2023.

EAS Education:

Explore EAS Academy for personalized learning. Knowledge is at your fingertips!

We understand that your time is valuable, and the pursuit of knowledge should be both flexible and accessible. That’s why EAS Academy offers a wealth of on-demand recordings for you to explore at your convenience.

Our on-demand recordings allow you to fit education into your busy schedule, whether you’re an early riser or a night owl. They’re available 24/7, giving you the flexibility to learn when it’s most convenient for you.

If you’re already an EAS member, make the most of your membership by actively using EAS Academy. It’s a valuable resource that’s definitely worth your while.

If you’re not yet a member, consider joining our society to take full advantage of this opportunity.

EAS Education:

Featured Plenary Session from EAS Congress 2023: Integrating the many players of cardiovascular risk

This week, we’ve handpicked a fantastic plenary session: Integrating the many players of cardiovascular risk from EAS Congress 2023 in Mannheim. Whether you’re looking to enhance your skills, stay updated on industry trends, or simply delve into a new area of expertise, our on-demand recordings have got you covered.

Don’t miss out on this week’s selection. Your schedule, your choice – embark on your path to endless learning with EAS Academy.

Click the specified image to watch the lecture.

Peter Libby, MD, is a cardiovascular specialist at Brigham and Women’s Hospital in Boston, Massachusetts, and holds the Mallinckrodt Professorship of Medicine at Harvard Medical School. His areas of clinical expertise include general and preventive cardiology.

His current major research focus is the role of inflammation in vascular diseases such as atherosclerosis. Dr. Libby has a particular devotion to translate his basic laboratory studies to pilot and then large-scale clinical cardiovascular outcome trials. He instigated and helped to lead the large-scale CANTOS trial that provided clinical validation of the role of inflammation in atherosclerosis.
An author and lecturer on cardiovascular medicine and atherosclerosis, Dr. Libby has published extensively in top ranked medical journals. He is the Editor-in Chief for the 12th edition of Braunwald’s Heart Disease.

Florian Kronenberg is Professor and Head of the Institute of Genetic Epidemiology at the Medical University of Innsbruck, Austria. He completed his medical degree at the University of Innsbruck and training in Medical Genetics in Gerd Utermann’s laboratory, and then worked at the Department of Cardiovascular Genetics, University of Utah, USA. He subsequently was appointed Head of the Research Unit “Genetic Epidemiology” at the Institute of Epidemiology, Helmholtz Center Munich before taking up his current position in 2004. His research interests include genetic and clinical epidemiological studies on lipoprotein(a), as well as the genetics of atherosclerosis, lipid disorders, kidney diseases, diabetes mellitus and related intermediate phenotypes. He served as a working group member on several guideline and consensus initiatives in the field of kidney disease as well as lipid metabolism.

Christos Mantzoros is Professor of Medicine at Harvard Medical School, Director of the Human Nutrition Unit, Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center, and Chief of Endocrinology, VA Boston Healthcare System, Boston, Massachusetts.

His research focuses on obesity, diabetes and adipokine biology. Dr Mantzoros serves as the Editor-in-Chief of Metabolism, Clinical and Experimental. He is the recipient of numerous awards and the scientific co-founder of Intekrin Metabolic Therapeutics.

Antonio Vidal-Puig is a Spanish medical doctor and scientist who works as a Professor of Molecular Nutrition and Metabolism at the University of Cambridge (UK), best known for advancing the concept that pharmacological targeting of brown fat may serve to treat overweight and obesity in affected individuals, as well as for introducing the concept of adipose tissue “expandability” as an important factor in the pathogenesis of insulin resistance in the context of positive energy balance.

His published work focuses on areas such as adipose tissue metabolism and lipotoxicity, regulation of insulin secretion, and the pathophysiology of metabolic syndrome, obesity, and type 2 diabetes.

EAS Education:

Rare Lipid Disorder courses are available on-demand

EAS conducts Rare Lipid Disorder Courses collaboratively organized with national societies in various countries and are stand alone, one-day events. They encompass a range of rare genetic disorders associated with lipid metabolism, such as ß-sitosterolemia, cerebrotendinous xanthomatosis, lysosomal acid lipase deficiency, disorders related to high-density lipoprotein, and familial hypocholesterolemias.

If you were not able to join courses live, it’s not too late! You can register and view them, free of charge, sometimes even in local languages. Check this out:

EAS Education:

Take advantage of your exclusive offer as a full individual EAS member and enroll in the course at a special discounted price

The Certificate of Excellence in Lipidology – 2023 Update offers you a valuable opportunity to become a genuine expert in the field of lipids and their impact on health.

This course has captured the attention of many professionals, and the opportunity to join is still open for you to take advantage of. As a special benefit, full individual EAS members can access an exclusive offer with a discount of over 30%.

EAS Society:

Take our member satisfaction survey

Give us your views on the types of member benefits we offer and your experience of them. Your responses will help us identify where we are succeeding, and where we can improve. The survey is anonymous, and will take ca. 4-5 minutes to answer.

We will use the results to inform the planning of future activities for our members. For each response we receive, EAS will donate 1 EUR to Médecins Sans Frontières.

Thank you in advance for your support – we look forward to hearing your views!